$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
瑞格非尼2021年医保报销后自费多少钱?
2025-10-19 11:44:20
Check Details
肝癌吃靶向药阿帕替尼多久有效果?
2025-10-19 11:44:20
Check Details
雷莫芦单抗是肝癌的二线治疗药物吗?
2025-10-19 11:44:20
Check Details
患者用瑞格非尼治疗肝癌多久见疗效?
2025-10-19 11:44:20
Check Details
阿帕替尼是什么靶向药物?多少钱一盒?
2025-10-19 11:44:20
Check Details
雷莫芦单抗治疗肝细胞癌的作用靶点
2025-10-19 11:44:20
Check Details
瑞格非尼可用于曾经接受过索拉非尼(多吉美)治疗过的肝癌细胞患者
2025-10-19 11:44:20
Check Details
阿帕替尼对肝癌晚期有怎样的疗效?
2025-10-19 11:44:20
Check Details
雷莫芦单抗获美国FDA批准用于肝细胞癌患者的治疗
2025-10-19 11:44:20
Check Details
靶向药阿帕替尼列入医保了吗?
2025-10-19 11:44:20
Check Details
用瑞格菲尼治疗肝癌多久见效?
2025-10-19 11:44:20
Check Details
阿帕替尼可用于既往接受过至少一线系统性治疗后失败或不可耐受的晚期肝细胞癌患者
2025-10-19 11:44:20
Check Details
1
2
...
8919
8920
8921
8922
8923
8924
8925
...
10207
10208
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
A Third-Gen EGFR-TKI Transforming Lung Cancer Treatment
2
Third-Generation TKI Redefining Treatment for ALK+ & ROS1+ NSCLC
3
IRX4 Transcription Factor: New Research Insights on Colorectal Cancer Treatment Targets
4
Ponesimod PONVORY: Novel Oral Treatment Option for Multiple Sclerosis
5
Lemborexant Side Effects and Medication Safety Complete Guide
6
Pegcetacoplan Side Effects and Medication Safety Complete Guide
7
Cabotegravir Sodium Side Effects and Medication Safety Complete Guide
8
Vericiguat Side Effects and Medication Safety Complete Guide
9
New Research Progress on Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Tumor Relationship
10
Pegcetacoplan (Empaveli): Complete Guide to PNH Complement Inhibitor Treatment
11
Cabotegravir Sodium (Vocabria): Complete Guide to HIV Long-Acting Treatment and Prevention
12
Eltrombopag: Innovative TPO Receptor Agonist for Treating Thrombocytopenia - Comprehensive Drug Analysis